Stock Price
75.48
Daily Change
1.72 2.33%
Monthly
-1.51%
Yearly
-27.63%
Q2 Forecast
71.84

Symrise reported EUR1.15B in Sales Revenues for its fiscal semester ending in December of 2025.





Sales Change Date
Avient USD 847M 86M Mar/2026
Chemours USD 1.4B 100M Mar/2026
Corteva USD 4.73B 820M Mar/2026
Covestro EUR 2.92B 255M Dec/2025
Symrise EUR 1.15B 70M Dec/2025
Victrex GBP 147.1M 71.6M Mar/2026